P2.10. Characteristics and Outcomes of Hispanic Patients with RET-Fusion Positive NSCLC Treated in Real-World Practice - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Oscar Arrieta
Meta Tag
Speaker Oscar Arrieta
Topic Metastatic NSCLC: Targeted Therapy - FUSIONS
Hispanic patients
RET-fusion positive non-small cell lung cancer
tyrosine kinase inhibitors
Latin American countries
clinicobiological features
tumor mutational burden
first-line treatment
progression-free survival
overall survival
RET-selective inhibitors
Powered By